Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
9.65
+0.03 (0.31%)
May 1, 2026, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $131.24 million as of May 1, 2026. Its market cap has increased by 38.63% in one year.
Market Cap
131.24M
Enterprise Value
116.33M
1-Year Change
38.63%
Ranking
Category
Stock Price
$9.65
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $131.24M, a decrease of -46.13%. That is a compound annual growth rate of -8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 130.83M | 103.80% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spero Therapeutics | 146.47M |
| Fate Therapeutics | 144.17M |
| Tenaya Therapeutics | 143.28M |
| InflaRx | 143.14M |
| Connect Biopharma Holdings | 143.00M |
| Kazia Therapeutics | 141.92M |
| Edesa Biotech | 141.28M |
| TuHURA Biosciences | 133.51M |